MedTrace Logo

Oral Mucositis in Patients Undergoing Antineoplastic Chemotherapy

NCT01036633 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 4

Last updated 2012-03-22

No results posted yet for this study

Summary

The purpose of this study was to:

1. To investigate the feasibility of using infrared (IR) thermometer to grade the severity of oral mucositis in patients with multiple myeloma undergoing chemotherapy.
2. To obtain preliminary data on the most optimal method of scoring the severity of oral mucositis by comparing the results obtained using the IR thermometer to the World Health Organization (WHO) mucositis grading system and the patient self-assessment questionnaire.
3. To Investigate the correlation between the quantitative readings obtained from oral mucosa with the IR thermometer.

Conditions

  • Oral Mucositis

Interventions

DEVICE

Infrared Thermometer

The infrared thermometer will be used to grade the severity of oral mucositis in patients undergoing antineoplastic chemotherapy for multiple myeloma. The photothermal camera will be used to take intraoral digital images of the mouth.

Sponsors & Collaborators

  • University of Arkansas

    lead OTHER

Principal Investigators

  • Emre Vural, MD · UAMS

  • Elias Anaissie, MD · UAMS

  • Gal Shafirstein, PhD · UAMS

Eligibility

Min Age
18 Years
Max Age
85 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2009-08-31
Primary Completion
2011-07-31
Completion
2011-07-31

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01036633 on ClinicalTrials.gov